Plasma Soluble Podoplanin As a Biomarker of Hypercoagulability and Cellular Immunity Status in Patients with Non-small Cell Lung Cancer.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS（2023）
Key words
non-small cell lung cancer,podoplanin,hypercoagulability,cellular immunity status,biomarker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined